Award Recognizes Breakthrough Innovation for INTELLISTENT®, Paving the Way for Citizens Worldwide to Receive Affordable, Cutting-Edge Cardiac Care NEW YORK , Oct. 25, 2023 /PRNewswire/ — HeartPoint Global is pleased to announce that INTELLISTENT® the company’s novel multi-lumen stent…

This New Milestone Follows the Company’s Successful Exploration of the HeartPoint Global Implant System in the Arterial Branches Ready for Clinical Trials to Start TEL AVIV, Israel, March 22, 2022 /PRNewswire/ — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, announced another major milestone in […]

Most Recent Pre-Clinical Trial Explored Placement in Arterial Branches Seeing Significant Results ISRAEL, Jan. 11, 2022 /PRNewswire/ — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, today announced a major milestone in ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS) in Israel. Following three […]